SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-279627
Filing Date
2019-10-31
Accepted
2019-10-31 07:38:01
Documents
20
Period of Report
2019-10-31
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d816482d8k.htm 8-K 21217
2 EX-99.1 d816482dex991.htm EX-99.1 35434
3 EX-99.2 d816482dex992.htm EX-99.2 24481
4 GRAPHIC g816482ex99_1p10g1.jpg GRAPHIC 165788
5 GRAPHIC g816482ex99_1p11g1.jpg GRAPHIC 201670
6 GRAPHIC g816482ex99_1p12g1.jpg GRAPHIC 197497
7 GRAPHIC g816482ex99_1p13g1.jpg GRAPHIC 216318
8 GRAPHIC g816482ex99_1p14g1.jpg GRAPHIC 212687
9 GRAPHIC g816482ex99_1p15g1.jpg GRAPHIC 350169
10 GRAPHIC g816482ex99_1p16g1.jpg GRAPHIC 317450
11 GRAPHIC g816482ex99_1p1g1.jpg GRAPHIC 242774
12 GRAPHIC g816482ex99_1p2g1.jpg GRAPHIC 415709
13 GRAPHIC g816482ex99_1p3g1.jpg GRAPHIC 325511
14 GRAPHIC g816482ex99_1p4g1.jpg GRAPHIC 317386
15 GRAPHIC g816482ex99_1p5g1.jpg GRAPHIC 267496
16 GRAPHIC g816482ex99_1p6g1.jpg GRAPHIC 320867
17 GRAPHIC g816482ex99_1p7g1.jpg GRAPHIC 320646
18 GRAPHIC g816482ex99_1p8g1.jpg GRAPHIC 239097
19 GRAPHIC g816482ex99_1p9g1.jpg GRAPHIC 228861
20 GRAPHIC g816482g1031060744061.jpg GRAPHIC 3160
  Complete submission text file 0001193125-19-279627.txt   6066824
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 191182119
SIC: 2834 Pharmaceutical Preparations